Clinical Trial Update: A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update of GX-G6 in patients with uncontrolled type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GX-G6

Snippet

Sponsor: Genexine, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN